Latest filing published 30 Dec 2010 for SELLAS Life Sciences Group, Inc., €4.4M.
Insider track record
No signal scores available.
Cytrx Corp: trading record in brief
All filings by Cytrx Corp on record concern SELLAS Life Sciences Group, Inc. The record holds 7 filings, for trades running from 11 March 2008 to 29 December 2010.
The open-market record consists of 5 sales worth €13.2M, with no purchase. 2010 to date brings no purchases and 4 sales.
Most recently, on 30 December 2010, the filings show an open-market sale worth €4.4M in SELLAS Life Sciences Group, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cytrx Corp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,593,881 shares@ US$2.20Common StockSEC:0001250853-10-000100:0
- 500,000 shares@ US$2.65Common StockSEC:0001250853-10-000099:0
- 2,000,000 shares@ US$2.55Common StockSEC:0001250853-10-000046:0
- 675,000 shares@ US$5.70Common StockSEC:0001250853-10-000045:0
- 500,000 shares@ US$2.50Common StockSEC:0001250853-09-000069:0
- 4,526,624 sharesCommon StockSEC:0001250853-08-000022:0
- 27,694 sharesCommon StockSEC:0001250853-08-000022:1
7 of 7 declarations